Feature

Survey: Health care costs, access unlikely to improve in 2019


 

U.S. physicians are not expecting to see improvements in health care costs and access in 2019, but most predict that the Affordable Care Act will make it through the year despite government efforts to defund it, according to a survey by health care market research company InCrowd.

Over 80% of the 200 physicians surveyed Dec. 20-22, 2018, said that it was somewhat or very unlikely that health care costs would improve over the course of this year, and almost 70% expressed those opinions regarding improved access to care. More than 70% said that the federal government will find ways to defund the ACA, but 60% believe that it will remain in place and almost 70% said that coverage for preexisting conditions will continue, InCrowd reported. A minority of respondents (45%) predicted that the quality of health care was very likely or somewhat likely to improve in 2019.

A number of other issues were covered in the survey: 71% of physicians predicted that children up to age 26 years will be able to stay on their parents’ coverage, 69% expect the insurance mandate to be eliminated, 58% believe that mental health coverage will be allowed, and 56% said that it is unlikely for more states to expand Medicaid, according to data from the 100 primary care physicians and 100 specialists who responded to the InCrowd MicroSurvey.

Recommended Reading

Revised ACA premium calculator could up uninsured rate
MDedge Hematology and Oncology
Trump zeroes in on surprise medical bills in White House chat with patients, experts
MDedge Hematology and Oncology
Survey: Americans support Medicare for all
MDedge Hematology and Oncology
Drug-pricing policies find new momentum as ‘a 2020 thing’
MDedge Hematology and Oncology
CMS proposing more flexibility in Medicare Advantage, Part D
MDedge Hematology and Oncology
Winners and losers under bold Trump plan to slash drug rebate deals
MDedge Hematology and Oncology
President Trump calls for end to HIV/AIDS, pediatric cancer
MDedge Hematology and Oncology
Cloud of inconsistency hangs over cannabis data
MDedge Hematology and Oncology
ALA report: Federal and state actions to limit tobacco use fall short
MDedge Hematology and Oncology
Conservatism spreads in prostate cancer
MDedge Hematology and Oncology